SICHUAN HZ-YEG MEDICAL Co Ltd
SZSE:300937
SICHUAN HZ-YEG MEDICAL Co Ltd
SZSE:300937
Price:
29.61
CNY
2.71%
Market Closed
Market Cap:
¥2.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
SICHUAN HZ-YEG MEDICAL Co Ltd
SZSE:300937
|
CN |
Income Statement
Earnings Waterfall
SICHUAN HZ-YEG MEDICAL Co Ltd
SICHUAN HZ-YEG MEDICAL Co Ltd
Income Statement
SICHUAN HZ-YEG MEDICAL Co Ltd
SICHUAN HZ-YEG MEDICAL Co Ltd
Currency: CNY
| Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||
| Interest Expense |
1
|
2
|
2
|
1
|
0
|
2
|
1
|
3
|
4
|
6
|
7
|
6
|
7
|
7
|
8
|
9
|
10
|
10
|
10
|
0
|
0
|
|
| Revenue |
1 985
N/A
|
2 790
+41%
|
2 917
+5%
|
3 049
+5%
|
3 172
+4%
|
3 401
+7%
|
3 480
+2%
|
3 565
+2%
|
3 677
+3%
|
3 969
+8%
|
4 181
+5%
|
4 416
+6%
|
4 499
+2%
|
4 430
-2%
|
4 546
+3%
|
4 451
-2%
|
4 454
+0%
|
4 381
-2%
|
4 281
-2%
|
4 313
+1%
|
4 387
+2%
|
|
| Gross Profit | ||||||||||||||||||||||
| Cost of Revenue |
(1 824)
|
(2 596)
|
(2 727)
|
(2 876)
|
(3 003)
|
(3 219)
|
(3 289)
|
(3 350)
|
(3 443)
|
(3 661)
|
(3 823)
|
(4 026)
|
(4 094)
|
(4 072)
|
(4 203)
|
(4 116)
|
(4 104)
|
(4 000)
|
(3 875)
|
(3 884)
|
(3 927)
|
|
| Gross Profit |
161
N/A
|
194
+21%
|
190
-2%
|
173
-9%
|
169
-2%
|
181
+7%
|
191
+5%
|
216
+13%
|
234
+9%
|
309
+32%
|
358
+16%
|
390
+9%
|
405
+4%
|
358
-11%
|
342
-4%
|
335
-2%
|
350
+4%
|
380
+9%
|
406
+7%
|
429
+6%
|
460
+7%
|
|
| Operating Income | ||||||||||||||||||||||
| Operating Expenses |
(98)
|
(133)
|
(138)
|
(133)
|
(136)
|
(180)
|
(177)
|
(208)
|
(216)
|
(252)
|
(275)
|
(281)
|
(302)
|
(287)
|
(296)
|
(305)
|
(321)
|
(356)
|
(379)
|
(408)
|
(440)
|
|
| Selling, General & Administrative |
(93)
|
(123)
|
(134)
|
(134)
|
(139)
|
(158)
|
(162)
|
(182)
|
(192)
|
(219)
|
(258)
|
(268)
|
(281)
|
(242)
|
(274)
|
(280)
|
(300)
|
(310)
|
(355)
|
(381)
|
(414)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
(11)
|
(16)
|
(20)
|
(24)
|
(17)
|
(17)
|
(18)
|
(19)
|
(19)
|
(19)
|
(19)
|
(18)
|
(15)
|
(13)
|
(12)
|
(11)
|
|
| Depreciation & Amortization |
(4)
|
(9)
|
0
|
0
|
0
|
(14)
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
(27)
|
0
|
0
|
0
|
(29)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
0
|
(1)
|
(4)
|
1
|
3
|
3
|
0
|
(6)
|
1
|
6
|
(0)
|
5
|
(3)
|
1
|
(2)
|
(6)
|
(4)
|
(1)
|
(11)
|
(16)
|
(15)
|
|
| Operating Income |
63
N/A
|
62
-3%
|
52
-16%
|
40
-23%
|
33
-18%
|
2
-95%
|
13
+727%
|
8
-39%
|
18
+129%
|
57
+209%
|
83
+46%
|
108
+31%
|
102
-6%
|
71
-30%
|
47
-35%
|
30
-36%
|
28
-5%
|
25
-13%
|
27
+11%
|
20
-25%
|
20
-1%
|
|
| Pre-Tax Income | ||||||||||||||||||||||
| Interest Income Expense |
(1)
|
(0)
|
(1)
|
10
|
10
|
0
|
4
|
(8)
|
(10)
|
(5)
|
(11)
|
(10)
|
(9)
|
(4)
|
(6)
|
(8)
|
(9)
|
(8)
|
(11)
|
(10)
|
(10)
|
|
| Non-Reccuring Items |
(0)
|
(0)
|
0
|
0
|
0
|
7
|
(0)
|
(0)
|
(0)
|
(5)
|
0
|
(0)
|
(0)
|
1
|
(0)
|
(1)
|
(1)
|
(0)
|
(1)
|
0
|
0
|
|
| Total Other Income |
2
|
1
|
1
|
1
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
1
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Pre-Tax Income |
64
N/A
|
62
-3%
|
51
-18%
|
50
-1%
|
41
-19%
|
8
-80%
|
16
+94%
|
(1)
N/A
|
8
N/A
|
45
+489%
|
70
+55%
|
97
+40%
|
92
-6%
|
70
-24%
|
42
-40%
|
22
-48%
|
19
-13%
|
17
-9%
|
17
-3%
|
11
-35%
|
10
-3%
|
|
| Net Income | ||||||||||||||||||||||
| Tax Provision |
(7)
|
(9)
|
(7)
|
(7)
|
(6)
|
(1)
|
(3)
|
(3)
|
(4)
|
(9)
|
(11)
|
(16)
|
(15)
|
(13)
|
(7)
|
(2)
|
(1)
|
(2)
|
(4)
|
(14)
|
(14)
|
|
| Income from Continuing Operations |
56
|
52
|
44
|
43
|
35
|
7
|
13
|
(4)
|
4
|
36
|
58
|
81
|
76
|
57
|
34
|
20
|
18
|
15
|
12
|
(4)
|
(3)
|
|
| Income to Minority Interest |
2
|
2
|
0
|
(3)
|
(2)
|
(0)
|
2
|
9
|
9
|
6
|
6
|
0
|
(1)
|
3
|
3
|
5
|
6
|
1
|
(1)
|
0
|
(3)
|
|
| Net Income (Common) |
59
N/A
|
54
-8%
|
45
-17%
|
40
-9%
|
33
-19%
|
6
-80%
|
14
+126%
|
5
-67%
|
12
+155%
|
42
+245%
|
65
+54%
|
81
+26%
|
75
-7%
|
60
-21%
|
37
-38%
|
25
-33%
|
23
-6%
|
16
-30%
|
11
-31%
|
(3)
N/A
|
(6)
-77%
|
|
| EPS (Diluted) |
0.82
N/A
|
0.75
-9%
|
0.46
-39%
|
0.48
+4%
|
0.29
-40%
|
0.07
-76%
|
0.16
+129%
|
0.05
-69%
|
0.13
+160%
|
0.44
+238%
|
0.67
+52%
|
0.85
+27%
|
0.79
-7%
|
0.62
-22%
|
0.39
-37%
|
0.26
-33%
|
0.24
-8%
|
0.17
-29%
|
0.12
-29%
|
-0.04
N/A
|
-0.06
-50%
|
|
Switch to:
Switch to:
See Also
Discover More
